摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-二甲基苯乙酮 | 3637-01-2

中文名称
3,4-二甲基苯乙酮
中文别名
1-(3,4-二甲基苯基)乙-1-酮;3',4'-二甲基苯乙酮
英文名称
3,4-dimethylacetophenone
英文别名
1-(3,4-dimethylphenyl)ethanone;1-(3,4-dimethylphenyl)ethan-1-one;3',4'-Dimethylacetophenone
3,4-二甲基苯乙酮化学式
CAS
3637-01-2
化学式
C10H12O
mdl
MFCD00008743
分子量
148.205
InChiKey
WPRAXAOJIODQJR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    -1.5°C
  • 沸点:
    243 °C(lit.)
  • 密度:
    1.001 g/mL at 25 °C(lit.)
  • 闪点:
    217 °F
  • LogP:
    2.590 (est)
  • 物理描述:
    Liquid
  • 保留指数:
    1828;1836;1831;1831;1823
  • 稳定性/保质期:
    - 常温常压下稳定,是一种无色透明的液体。 - 它存在于烟气中。

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • TSCA:
    Yes
  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xn
  • 安全说明:
    S26,S39
  • 危险类别码:
    R20/22,R36
  • WGK Germany:
    3
  • 海关编码:
    2914399090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H317,H319
  • 储存条件:
    请将药品存放在避光阴凉、干燥的地方,并密封保存。

SDS

SDS:af676319e58d334e23ffacbb8def3d9d
查看
Name: 3 4 -Dimethylacetophenone 97% Material Safety Data Sheet
Synonym: None
CAS: 3637-01-2
Section 1 - Chemical Product MSDS Name:3 4 -Dimethylacetophenone 97% Material Safety Data Sheet
Synonym:None

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
3637-01-2 3',4'-Dimethylacetophenone, 97% 97% 222-859-2
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid if cough or other symptoms appear.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Wash hands before eating. Use with adequate ventilation. Do not get on skin or in eyes. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 3637-01-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: clear, colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 243 deg C @ 760.00mm Hg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 102 deg C ( 215.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.0010g/cm3
Molecular Formula: C10H12O
Molecular Weight: 148.20

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents and strong bases.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 3637-01-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3',4'-Dimethylacetophenone, 97% - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 3637-01-2: No information available.
Canada
CAS# 3637-01-2 is listed on Canada's DSL List.
CAS# 3637-01-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 3637-01-2 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质:无色透明的液体。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4

反应信息

  • 作为反应物:
    描述:
    3,4-二甲基苯乙酮 在 lithium aluminium tetrahydride 、 三氯化铝乙醚 作用下, 生成 4-乙基邻二甲苯
    参考文献:
    名称:
    Reduction of Organic Compounds by Mixed Hydrides. II. Hydrogenolysis of Ketones and Alcohols1
    摘要:
    DOI:
    10.1021/ja01544a075
  • 作为产物:
    描述:
    葑酮硫酸 作用下, 生成 3,4-二甲基苯乙酮
    参考文献:
    名称:
    CVI.—硫酸对fenchone的作用
    摘要:
    DOI:
    10.1039/ct8997501058
  • 作为试剂:
    描述:
    对溴甲苯1-(3,4-二甲基苯基)乙醇 在 bis-triphenylphosphine-palladium(II) chloride 、 5,5’-bis(diphenylphosphino)-4,4’-bi-1,3-benzodioxole 、 sodium t-butanolate3,4-二甲基苯乙酮 作用下, 以 对二甲苯 为溶剂, 以71 %的产率得到1-(3,4-dimethylphenyl)-2-(p-tolyl)ethan-1-ol
    参考文献:
    名称:
    外消旋仲苯甲醇的 β-芳基化以获得对映体丰富的 β-芳基化醇
    摘要:
    使用单一 Pd 催化剂,通过 MPV 型氢转移过程实现的借氢催化,开发了仲醇与芳基溴的 β-芳基化的第一个例子。此外,在Pd和Ru的催化下也实现了该反应的对映异构体,使得外消旋仲醇转化为具有良好对映选择性的对映异构体丰富的手性醇。
    DOI:
    10.1002/anie.202306015
点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED HETEROCYCLES AS BROMODOMAIN INHIBITORS<br/>[FR] HÉTÉROCYCLES SUBSTITUÉS À TITRE D'INHIBITEURS DE BROMODOMAINES
    申请人:ZENITH EPIGENETICS CORP
    公开号:WO2016092375A1
    公开(公告)日:2016-06-16
    The present application relates to substituted heterocycles compound of Formula I and pharmaceutical compositions thereof useful for the inhibition of BET protein function by binding to bromodomains (Formula I).
    本申请涉及Formula I的取代杂环化合物及其制药组合物,用于通过结合溴结构域(Formula I)抑制BET蛋白功能。
  • Iron-Catalyzed Synthesis of 2<i>H</i>-Imidazoles from Oxime Acetates and Vinyl Azides under Redox-Neutral Conditions
    作者:Zhongzhi Zhu、Xiaodong Tang、Jianxiao Li、Xianwei Li、Wanqing Wu、Guohua Deng、Huanfeng Jiang
    DOI:10.1021/acs.orglett.7b00203
    日期:2017.3.17
    A novel and versatile method for the synthesis of 2H-imidazoles via iron-catalyzed [3 + 2] annulation from readily available oxime acetates with vinyl azides has been developed. This denitrogenative process involved N–O/N–N bond cleavages and two C–N bond formations to furnish 2,4-substituted 2H-imidazoles. This protocol was performed under mild reaction conditions and needed no additives or ligands
    已开发出一种新颖且通用的方法,该方法通过铁催化的[3 + 2]环合反应从易于获得的肟肟与叠氮化乙烯中合成2 H-咪唑。该脱氮过程涉及N–O / N–N键断裂和两个C–N键形成,以提供2,4-取代的2 H-咪唑。该方案在温和的反应条件下进行,不需要添加剂或配体。此外,这是绿色反应,涉及乙酸肟肟作为内部氧化剂,乙酸和氮作为副产物。
  • Synthesis of Isoquinoline Derivatives via Palladium‐Catalyzed C−H/C−N Bond Activation of <i>N</i> ‐Acyl Hydrazones with <i>α</i> ‐Substituted Vinyl Azides
    作者:Biao Nie、Wanqing Wu、Wei Zeng、Qingyun Ren、Ji Zhang、Yingjun Zhang、Huanfeng Jiang
    DOI:10.1002/adsc.201901394
    日期:2020.3.17
    A palladiumcatalyzed cyclization of N‐acetyl hydrazones with vinyl azides has been developed. Various substituted isoquinolines, including diverse fused isoquinolines can be prepared via this protocol in moderate to good yields. Mechanistic studies suggest that α‐substituted vinyl azide serves as an internal nitrogen source. Also, C−H bond activation and C−N bond cleavage have been realized using
    已经开发了钯催化的乙烯基叠氮化物对N乙酰基hydr的环化反应。可以通过该方案以中等至良好的产率制备各种取代的异喹啉,包括各种稠合的异喹啉。机理研究表明,α-取代的叠氮化乙烯可作为内部氮源。另外,使用作为指导基团已经实现了CH键的活化和CN键的裂解。
  • Copper-catalyzed synthesis of thiazol-2-yl ethers from oxime acetates and xanthates under redox-neutral conditions
    作者:Zhongzhi Zhu、Xiaodong Tang、Jinghe Cen、Jianxiao Li、Wanqing Wu、Huanfeng Jiang
    DOI:10.1039/c8cc00445e
    日期:——
    acetates and xanthates for the synthesis of thiazol-2-yl ethers with remarkable regioselectivity has been developed. Various oxime acetates, whether derived from aryl ketones or alkyl ketones, or natural product cores are suitable for this conversion. Unique dihydrothiazoles were also obtained when both reaction sites were methine. Mechanistic studies indicated that imino copper(III) intermediates were involved
    新型的铜催化的肟肟酸酯和黄药酸酯的环化反应用于合成噻唑-2-基醚,具有显着的区域选择性。各种衍生自芳基酮或烷基酮的乙酸肟酯,或天然产物核均适用于该转化。当两个反应位点均为次甲基时,也获得了独特的二氢噻唑。机理研究表明,涉及亚氨基铜(III)中间体。另外,该方案在氧化还原中性条件下进行,不需要添加剂或配体。
  • 酮与alpha氯代酮一步反应合成呋喃类化合物的方法
    申请人:重庆医科大学
    公开号:CN113861137B
    公开(公告)日:2023-08-15
    本发明提供一种以alpha‑氯代酮和甲基酮或环酮为原料,在略微过量的钛酸四异丙酯作用下,无溶剂条件下一步反应制备多取代呋喃化合物的方法。即在惰性气体保护下,将甲基酮或环酮、α‑氯代酮和对甲苯磺酸的反应混合物搅拌加热升温后,加入钛酸四异丙酯进行反应,反应结束后再将所得反应混合物进行分离提纯,得到多取代呋喃化合物。本发明所述的合成方法,原料易得,成本低廉,操作简单易控,无需溶剂,有良好的底物普适性和官能团兼容性,适宜于工业化大生产。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
mass
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台